We appreciate the authors’ important contribution on post-discharge outcomes in community-acquired pneumonia (CAP)[1]. One key concern lies in the treatment of “immunosuppression” as a unitary exposure in the main analysis, despite the methodological distinction between disease-related and drug-related causes. While this approach improves model parsimony, it underestimates clinically meaningful heterogeneity.
